Рет қаралды 45
In this MDA Advocacy Institute, we cover updates on our plans for the last few weeks of 2024 and discuss how we’re urging Congress to finalize critical legislation for the neuromuscular disease community, including the Accelerating Kids’ Access to Care Act and the Rare Pediatric Disease Priority Review Voucher program reauthorization.